Jeffrey A. Knauf
0000-0003-4456-8792
Publication & Citation Trends
Publications
0 total
Development of animal models to study aggressive thyroid cancers OA
Cited by 1
Semantic Scholar
Loss of tumor cell MHC class II drives MAPK inhibitor insensitivity of BRAF-mutant anaplastic thyroid cancers
Cited by 0
Semantic Scholar
Loss of tumor cell MHC Class II drives insensitivity of BRAF-mutant anaplastic thyroid cancers to MAPK inhibitors
Cited by 2
Semantic Scholar
Abstract 2552: TET2-mutant clonal hematopoiesis enrichment in the tumor microenvironment is an actionable driver of treatment resistance in solid tumors: Thyroid cancer as a paradigm
Cited by 0
Semantic Scholar
RBM10 loss promotes metastases by aberrant splicing of cytoskeletal and extracellular matrix mRNAs.
Cited by 10
Semantic Scholar
Pilot study evaluating the addition of cemiplimab in BRAF-mutant anaplastic thyroid cancer after progression on dabrafenib and trametinib.
Cited by 1
Semantic Scholar
Targetable treatment resistance in thyroid cancer with clonal hematopoiesis OA
Cited by 7
Semantic Scholar
RBM10 loss induces aberrant splicing of cytoskeletal and extracellular matrix mRNAs and promotes metastatic fitness
Cited by 1
Semantic Scholar
Research Topics
Thyroid Cancer Diagnosis and Treatment
(156)
Nutrition, Genetics, and Disease
(76)
Cancer-related Molecular Pathways
(56)
Chromatin Remodeling and Cancer
(36)
Cancer Mechanisms and Therapy
(28)
Affiliations
Cedars-Sinai Medical Center
University Hospitals Birmingham NHS Foundation Trust
Cleveland Clinic
Memorial Sloan Kettering Cancer Center
Los Alamos National Laboratory